Prasugrel
پراسوگرل
🩸 Blood And Blood Forming OrgansP2Y12 inhibitor (antiplatelet)
Market / country: 🇺🇸 USA
Effient (US)
🧮 Dose calculator
Acute coronary syndrome / post-MI · Regimen source: FDA Prasugrel · 2
- • Start with a single 60 mg loading dose, then daily. With aspirin 75–325 mg daily. Generally not recommended at ≥75 y. FDA Prasugrel · 2FDA Prasugrel · 5
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Active pathological bleeding; prior TIA or stroke; hypersensitivity. FDA Prasugrel · 4
Warnings
- • Boxed warning: significant, sometimes fatal bleeding. Generally not recommended at ≥75 y. Stop 7 days before surgery. FDA Prasugrel · Boxed Warning
Formulations
- 5 mg tablet — tablet 🇺🇸 USA FDA Prasugrel · 3
- 10 mg tablet — tablet 🇺🇸 USA FDA Prasugrel · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Prasugrel · 8.1
“Risk Summary There are no data with prasugrel tablets use in pregnant women to inform a drug-associated risk.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Prasugrel · 8.2
“Risk Summary There is no information regarding the presence of prasugrel in human milk, the effects on the breastfed infant, or the effects on milk production.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Prasugrel · 8.4
“Safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Prasugrel · 8.5
“… ory of myocardial infarction) where its effect appears to be greater and its use may be considered [see Warnings and Precautions ( 5.1 ), Clinical Pharmacology ( 12.3 ), and Clinical Studies ( 14 )] .”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA205897
- DailyMed (FDA label)FDA Prasugrel
- MedlinePlus (NIH)Prasugrel
- WHO ATC/DDDB01AC22
- Darooyab (Iran)Prasugrel
🇮🇷 Registered in Iran Darooyab · G-4733/Prasugrel
Dosage forms with Iranian generic codes, per Darooyab.
- 16009 · PRASUGREL 10MG TAB · قرص پراسوگرل ۱۰ میلیگرم
- 16010 · PRASUGREL 5MG TAB · قرص پراسوگرل ۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Prasugrel · 3FDA Prasugrel · 2FDA Prasugrel · 5FDA Prasugrel · 4FDA Prasugrel · Boxed WarningFDA Prasugrel · 8.1FDA Prasugrel · 8.2FDA Prasugrel · 8.4FDA Prasugrel · 8.5FDA Prasugrel · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-4733/Prasugrel
- Clinical review⚠ Unverified